Market news

PLYMOUTH MEETING, Pa., September 11, 2026--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today announced today that they will participate in the following upcoming investor conferences:

Detailed price information for Zimmer Biomet Holdings (ZBH-N) from The Globe and Mail including charting and trades.

Shares of healthcare services provider AdaptHealth Corp. (NASDAQ:AHCO) fell 8.6% in the afternoon session after the company announced the appointment of Harriss T. Currie as Chief Financial Officer, taking over duties from Jason Clemens.

Detailed price information for Adapthealth Corp Cl. A (AHCO-Q) from The Globe and Mail including charting and trades.

AdaptHealth (AHCO) said late Tuesday it has appointed Harriss Currie as chief financial officer, eff

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how AdaptHealth (NASDAQ:AHCO) and the rest of the senior health, home health & hospice stocks fared in Q2.

Detailed price information for Adapthealth Corp Cl. A (AHCO-Q) from The Globe and Mail including charting and trades.

Detailed price information for United Therapeutic (UTHR-Q) from The Globe and Mail including charting and trades.

AdaptHealth’s second quarter results prompted a significant negative market reaction, as the company reported both revenue and profitability well below Wall Street’s expectations. Management attributed this to a combination of operational inefficiencies in its large West Coast capitated contract and cost pressures from a sudden supplier price increase. CEO Suzanne Foster described the unexpected operational challenges as “not sustainable,” highlighting elevated costs from higher-than-anticipated

Detailed price information for Humana Inc (HUM-N) from The Globe and Mail including charting and trades.

AdaptHealth (NASDAQ:AHCO) executives outlined the company’s second-quarter performance, portfolio changes and plans to focus capital on sleep, respiratory and home medical equipment businesses during a Canaccord conference discussion. Chief Executive Officer Suzanne Foster said the company has spen

Detailed price information for Adapthealth Corp Cl. A (AHCO-Q) from The Globe and Mail including charting and trades.

AdaptHealth delivered news to investors this week that crushed its share price.

Detailed price information for Wayfair Inc (W-N) from The Globe and Mail including charting and trades.

Detailed price information for Adapthealth Corp Cl. A (AHCO-Q) from The Globe and Mail including charting and trades.

AdaptHealth (AHCO) has an average rating of buy and mean price target of $11.86, according to analys

Moby summary of AdaptHealth Corp.'s Q2 2026 earnings call

AdaptHealth Corp (AHCO) navigates a transformative quarter with diabetes divestiture and Humana expansion, despite facing significant contract and pricing challenges.

AdaptHealth (NASDAQ:AHCO) reported second-quarter revenue growth in its continuing operations but lowered its full-year profitability outlook, citing higher-than-expected costs in its West Coast capitated contract, a supplier price increase and portfolio actions. Chief Executive Officer Suzanne Fos

AdaptHealth (AHCO) reported a Q2 loss Tuesday of $0.99 per diluted share, compared with earnings of

CONSHOHOCKEN, Pa., August 04, 2026--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the second quarter ended June 30, 2026.

Detailed price information for Adapthealth Corp Cl. A (AHCO-Q) from The Globe and Mail including charting and trades.

Healthcare services provider AdaptHealth Corp. (NASDAQ:AHCO) fell short of the market’s revenue expectations in Q2 CY2026, with sales falling 7.5% year on year to $740.3 million. The company’s full-year revenue guidance of $2.87 billion at the midpoint came in 17.7% below analysts’ estimates. Its GAAP loss of $0.99 per share was significantly below analysts’ consensus estimates.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Healthcare services provider AdaptHealth Corp. (NASDAQ:AHCO) will be reporting earnings this Tuesday before market hours. Here’s what you need to know.

Detailed price information for Adapthealth Corp Cl. A (AHCO-Q) from The Globe and Mail including charting and trades.